Global Bronchiectasis Drugs Market Growth (Status and Outlook) 2025-2031

December 2025 | 75 pages | ID: GA3C466EFF5FEN
LP Information

Abstracts

According to this study, the global Bronchiectasis Drugs market size will reach US$ million by 2031.

Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Bronchiectasis Drugs Industry Forecast” looks at past sales and reviews total world Bronchiectasis Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Bronchiectasis Drugs sales for 2025 through 2031. With Bronchiectasis Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bronchiectasis Drugs industry.

This Insight Report provides a comprehensive analysis of the global Bronchiectasis Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bronchiectasis Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bronchiectasis Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bronchiectasis Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bronchiectasis Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Bronchiectasis Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Antibiotics
• Expectorants
• Other drugs

Segmentation by Application:

• Hospital
• Research institute
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Endo International Plc
• GlaxoSmithKline Plc
• Neopharma LLC
• Pfizer Inc.
• Reckitt Benckiser Group Plc

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bronchiectasis Drugs Market Size (2020-2031)
  2.1.2 Bronchiectasis Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Bronchiectasis Drugs by Country/Region (2020, 2024 & 2031)
2.2 Bronchiectasis Drugs Segment by Type
  2.2.1 Antibiotics
  2.2.2 Expectorants
  2.2.3 Other drugs
2.3 Bronchiectasis Drugs Market Size by Type
  2.3.1 Bronchiectasis Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Bronchiectasis Drugs Market Size Market Share by Type (2020-2025)
2.4 Bronchiectasis Drugs Segment by Application
  2.4.1 Hospital
  2.4.2 Research institute
  2.4.3 Clinic
  2.4.4 Other
2.5 Bronchiectasis Drugs Market Size by Application
  2.5.1 Bronchiectasis Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Bronchiectasis Drugs Market Size Market Share by Application (2020-2025)

3 BRONCHIECTASIS DRUGS MARKET SIZE BY PLAYER

3.1 Bronchiectasis Drugs Market Size Market Share by Player
  3.1.1 Global Bronchiectasis Drugs Revenue by Player (2020-2025)
  3.1.2 Global Bronchiectasis Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Bronchiectasis Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BRONCHIECTASIS DRUGS BY REGION

4.1 Bronchiectasis Drugs Market Size by Region (2020-2025)
4.2 Global Bronchiectasis Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bronchiectasis Drugs Market Size Growth (2020-2025)
4.4 APAC Bronchiectasis Drugs Market Size Growth (2020-2025)
4.5 Europe Bronchiectasis Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Bronchiectasis Drugs Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Bronchiectasis Drugs Market Size by Country (2020-2025)
5.2 Americas Bronchiectasis Drugs Market Size by Type (2020-2025)
5.3 Americas Bronchiectasis Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bronchiectasis Drugs Market Size by Region (2020-2025)
6.2 APAC Bronchiectasis Drugs Market Size by Type (2020-2025)
6.3 APAC Bronchiectasis Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Bronchiectasis Drugs Market Size by Country (2020-2025)
7.2 Europe Bronchiectasis Drugs Market Size by Type (2020-2025)
7.3 Europe Bronchiectasis Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bronchiectasis Drugs by Region (2020-2025)
8.2 Middle East & Africa Bronchiectasis Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Bronchiectasis Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BRONCHIECTASIS DRUGS MARKET FORECAST

10.1 Global Bronchiectasis Drugs Forecast by Region (2026-2031)
  10.1.1 Global Bronchiectasis Drugs Forecast by Region (2026-2031)
  10.1.2 Americas Bronchiectasis Drugs Forecast
  10.1.3 APAC Bronchiectasis Drugs Forecast
  10.1.4 Europe Bronchiectasis Drugs Forecast
  10.1.5 Middle East & Africa Bronchiectasis Drugs Forecast
10.2 Americas Bronchiectasis Drugs Forecast by Country (2026-2031)
  10.2.1 United States Market Bronchiectasis Drugs Forecast
  10.2.2 Canada Market Bronchiectasis Drugs Forecast
  10.2.3 Mexico Market Bronchiectasis Drugs Forecast
  10.2.4 Brazil Market Bronchiectasis Drugs Forecast
10.3 APAC Bronchiectasis Drugs Forecast by Region (2026-2031)
  10.3.1 China Bronchiectasis Drugs Market Forecast
  10.3.2 Japan Market Bronchiectasis Drugs Forecast
  10.3.3 Korea Market Bronchiectasis Drugs Forecast
  10.3.4 Southeast Asia Market Bronchiectasis Drugs Forecast
  10.3.5 India Market Bronchiectasis Drugs Forecast
  10.3.6 Australia Market Bronchiectasis Drugs Forecast
10.4 Europe Bronchiectasis Drugs Forecast by Country (2026-2031)
  10.4.1 Germany Market Bronchiectasis Drugs Forecast
  10.4.2 France Market Bronchiectasis Drugs Forecast
  10.4.3 UK Market Bronchiectasis Drugs Forecast
  10.4.4 Italy Market Bronchiectasis Drugs Forecast
  10.4.5 Russia Market Bronchiectasis Drugs Forecast
10.5 Middle East & Africa Bronchiectasis Drugs Forecast by Region (2026-2031)
  10.5.1 Egypt Market Bronchiectasis Drugs Forecast
  10.5.2 South Africa Market Bronchiectasis Drugs Forecast
  10.5.3 Israel Market Bronchiectasis Drugs Forecast
  10.5.4 Turkey Market Bronchiectasis Drugs Forecast
10.6 Global Bronchiectasis Drugs Forecast by Type (2026-2031)
10.7 Global Bronchiectasis Drugs Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Bronchiectasis Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Endo International Plc
  11.1.1 Endo International Plc Company Information
  11.1.2 Endo International Plc Bronchiectasis Drugs Product Offered
  11.1.3 Endo International Plc Bronchiectasis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Endo International Plc Main Business Overview
  11.1.5 Endo International Plc Latest Developments
11.2 GlaxoSmithKline Plc
  11.2.1 GlaxoSmithKline Plc Company Information
  11.2.2 GlaxoSmithKline Plc Bronchiectasis Drugs Product Offered
  11.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 GlaxoSmithKline Plc Main Business Overview
  11.2.5 GlaxoSmithKline Plc Latest Developments
11.3 Neopharma LLC
  11.3.1 Neopharma LLC Company Information
  11.3.2 Neopharma LLC Bronchiectasis Drugs Product Offered
  11.3.3 Neopharma LLC Bronchiectasis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Neopharma LLC Main Business Overview
  11.3.5 Neopharma LLC Latest Developments
11.4 Pfizer Inc.
  11.4.1 Pfizer Inc. Company Information
  11.4.2 Pfizer Inc. Bronchiectasis Drugs Product Offered
  11.4.3 Pfizer Inc. Bronchiectasis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Pfizer Inc. Main Business Overview
  11.4.5 Pfizer Inc. Latest Developments
11.5 Reckitt Benckiser Group Plc
  11.5.1 Reckitt Benckiser Group Plc Company Information
  11.5.2 Reckitt Benckiser Group Plc Bronchiectasis Drugs Product Offered
  11.5.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Reckitt Benckiser Group Plc Main Business Overview
  11.5.5 Reckitt Benckiser Group Plc Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Bronchiectasis Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Bronchiectasis Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antibiotics
Table 4. Major Players of Expectorants
Table 5. Major Players of Other drugs
Table 6. Bronchiectasis Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Bronchiectasis Drugs Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Bronchiectasis Drugs Market Size Market Share by Type (2020-2025)
Table 9. Bronchiectasis Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Bronchiectasis Drugs Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Bronchiectasis Drugs Market Size Market Share by Application (2020-2025)
Table 12. Global Bronchiectasis Drugs Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Bronchiectasis Drugs Revenue Market Share by Player (2020-2025)
Table 14. Bronchiectasis Drugs Key Players Head office and Products Offered
Table 15. Bronchiectasis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Bronchiectasis Drugs Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Bronchiectasis Drugs Market Size Market Share by Region (2020-2025)
Table 20. Global Bronchiectasis Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Bronchiectasis Drugs Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Bronchiectasis Drugs Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Bronchiectasis Drugs Market Size Market Share by Country (2020-2025)
Table 24. Americas Bronchiectasis Drugs Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Bronchiectasis Drugs Market Size Market Share by Type (2020-2025)
Table 26. Americas Bronchiectasis Drugs Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Bronchiectasis Drugs Market Size Market Share by Application (2020-2025)
Table 28. APAC Bronchiectasis Drugs Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Bronchiectasis Drugs Market Size Market Share by Region (2020-2025)
Table 30. APAC Bronchiectasis Drugs Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Bronchiectasis Drugs Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Bronchiectasis Drugs Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Bronchiectasis Drugs Market Size Market Share by Country (2020-2025)
Table 34. Europe Bronchiectasis Drugs Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Bronchiectasis Drugs Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Bronchiectasis Drugs Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Bronchiectasis Drugs Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Bronchiectasis Drugs Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Bronchiectasis Drugs
Table 40. Key Market Challenges & Risks of Bronchiectasis Drugs
Table 41. Key Industry Trends of Bronchiectasis Drugs
Table 42. Global Bronchiectasis Drugs Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Bronchiectasis Drugs Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Bronchiectasis Drugs Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Bronchiectasis Drugs Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Endo International Plc Details, Company Type, Bronchiectasis Drugs Area Served and Its Competitors
Table 47. Endo International Plc Bronchiectasis Drugs Product Offered
Table 48. Endo International Plc Bronchiectasis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Endo International Plc Main Business
Table 50. Endo International Plc Latest Developments
Table 51. GlaxoSmithKline Plc Details, Company Type, Bronchiectasis Drugs Area Served and Its Competitors
Table 52. GlaxoSmithKline Plc Bronchiectasis Drugs Product Offered
Table 53. GlaxoSmithKline Plc Bronchiectasis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. GlaxoSmithKline Plc Main Business
Table 55. GlaxoSmithKline Plc Latest Developments
Table 56. Neopharma LLC Details, Company Type, Bronchiectasis Drugs Area Served and Its Competitors
Table 57. Neopharma LLC Bronchiectasis Drugs Product Offered
Table 58. Neopharma LLC Bronchiectasis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Neopharma LLC Main Business
Table 60. Neopharma LLC Latest Developments
Table 61. Pfizer Inc. Details, Company Type, Bronchiectasis Drugs Area Served and Its Competitors
Table 62. Pfizer Inc. Bronchiectasis Drugs Product Offered
Table 63. Pfizer Inc. Bronchiectasis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Pfizer Inc. Main Business
Table 65. Pfizer Inc. Latest Developments
Table 66. Reckitt Benckiser Group Plc Details, Company Type, Bronchiectasis Drugs Area Served and Its Competitors
Table 67. Reckitt Benckiser Group Plc Bronchiectasis Drugs Product Offered
Table 68. Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Reckitt Benckiser Group Plc Main Business
Table 70. Reckitt Benckiser Group Plc Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Bronchiectasis Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bronchiectasis Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Bronchiectasis Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Bronchiectasis Drugs Sales Market Share by Country/Region (2024)
Figure 8. Bronchiectasis Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Bronchiectasis Drugs Market Size Market Share by Type in 2024
Figure 10. Bronchiectasis Drugs in Hospital
Figure 11. Global Bronchiectasis Drugs Market: Hospital (2020-2025) & ($ millions)
Figure 12. Bronchiectasis Drugs in Research institute
Figure 13. Global Bronchiectasis Drugs Market: Research institute (2020-2025) & ($ millions)
Figure 14. Bronchiectasis Drugs in Clinic
Figure 15. Global Bronchiectasis Drugs Market: Clinic (2020-2025) & ($ millions)
Figure 16. Bronchiectasis Drugs in Other
Figure 17. Global Bronchiectasis Drugs Market: Other (2020-2025) & ($ millions)
Figure 18. Global Bronchiectasis Drugs Market Size Market Share by Application in 2024
Figure 19. Global Bronchiectasis Drugs Revenue Market Share by Player in 2024
Figure 20. Global Bronchiectasis Drugs Market Size Market Share by Region (2020-2025)
Figure 21. Americas Bronchiectasis Drugs Market Size 2020-2025 ($ millions)
Figure 22. APAC Bronchiectasis Drugs Market Size 2020-2025 ($ millions)
Figure 23. Europe Bronchiectasis Drugs Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Bronchiectasis Drugs Market Size 2020-2025 ($ millions)
Figure 25. Americas Bronchiectasis Drugs Value Market Share by Country in 2024
Figure 26. United States Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Bronchiectasis Drugs Market Size Market Share by Region in 2024
Figure 31. APAC Bronchiectasis Drugs Market Size Market Share by Type (2020-2025)
Figure 32. APAC Bronchiectasis Drugs Market Size Market Share by Application (2020-2025)
Figure 33. China Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 37. India Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Bronchiectasis Drugs Market Size Market Share by Country in 2024
Figure 40. Europe Bronchiectasis Drugs Market Size Market Share by Type (2020-2025)
Figure 41. Europe Bronchiectasis Drugs Market Size Market Share by Application (2020-2025)
Figure 42. Germany Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. France Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Bronchiectasis Drugs Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Bronchiectasis Drugs Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Bronchiectasis Drugs Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Bronchiectasis Drugs Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 56. APAC Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 57. Europe Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 59. United States Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 60. Canada Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 61. Mexico Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 62. Brazil Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 63. China Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 64. Japan Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 65. Korea Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 67. India Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 68. Australia Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 69. Germany Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 70. France Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 71. UK Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 72. Italy Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 73. Russia Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 74. Egypt Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 75. South Africa Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 76. Israel Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 77. Turkey Bronchiectasis Drugs Market Size 2026-2031 ($ millions)
Figure 78. Global Bronchiectasis Drugs Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Bronchiectasis Drugs Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Bronchiectasis Drugs Market Size 2026-2031 ($ millions)